FibroGen Stock Plummets 30% In 21 Sessions: Is It Time To Sell?

(VIANEWS) – FibroGen (NASDAQ: FGEN) shares have seen an extraordinary decline of 30.15% over the last 21 sessions, falling from EUR1.36 to EUR0.95, continuing their downward momentum from prior sessions. Even as NASDAQ rose 0.83% to EUR13,928.34 during this time, FibroGen’s performance remains weak with their last closing price being EUR0.93, representing an approximately 96%…

Read More

Less Than One Hour Before The Market Open, Alnylam Pharmaceuticals Is Down By 5%

(VIANEWS) – The NASDAQ opens in less than one hour and Alnylam Pharmaceuticals‘s pre-market value is already 5.58% down. Alnylam Pharmaceuticals’s last close was $211.65, 12.89% below its 52-week high of $242.97. The last session, NASDAQ ended with Alnylam Pharmaceuticals (ALNY) dropping 0% to $211.65. NASDAQ rose 0.29% to $13,813.58, following the last session’s upward…

Read More

Platinum Futures Bearish Momentum With A 6% Drop In The Last 10 Sessions

(VIANEWS) – Platinum (PL) has been up by 6.65% for the last 10 sessions. At 05:52 EST on Thursday, 14 September, Platinum (PL) is $903.90. Volume Today’s last reported volume for Platinum is 4390, 99.99% below its average volume of 9228130887.44. Volatility Platinum’s last week, last month’s, and last quarter’s current intraday variation average was…

Read More